Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» GSK
GSK
GSK, Moderna fight over ‘COVID MVAX’ trademark. What does it mean for pharma?
Medical Marketing and Media
Thu, 08/24/23 - 09:51 pm
GSK
Moderna Therapeutics
trademark
vaccines
COVID-19
In GSK's trial of shingles vaccine in China, Shingrix keeps it 100
Fierce Pharma
Wed, 08/23/23 - 10:54 am
GSK
vaccines
shingles
Shingrix
China
Malaria vaccine-drug combo achieves 'dramatic' results
Pharmaphorum
Wed, 08/23/23 - 09:58 am
GSK
Mosquirix
malaria
vaccines
clinical trials
GSK stays a step ahead in RSV vaccine battle as Arexvy becomes available at US pharmacies
Fierce Pharma
Thu, 08/17/23 - 07:50 pm
GSK
RSV
vaccines
Arexvy
Pfizer
Moderna Therapeutics
The 10 drugs that CMS might wrangle into negotiations
Beckers Hospital Review
Wed, 08/16/23 - 10:16 am
CMS
Medicare
drug pricing
Bristol Myers Squibb
Janssen
Merck
Pfizer
Amgen
Boehringer Ingelheim
Pharmacyclics
AstraZeneca
Astellas
GSK
GSK Sues Pfizer for Alleged RSV Vaccine Patent Infringement
BioSpace
Wed, 08/2/23 - 10:45 pm
GSK
Pfizer
RSV
vaccines
legal
Patent Infringement
GSK beats Merck to first PD-1 approval in newly diagnosed endometrial cancer
Fierce Pharma
Mon, 07/31/23 - 09:59 pm
GSK
FDA
immunotherapy
endometrial cancer
Jemperli
Big Pharma CEOs get candid about pricing and M&A
Pharma Voice
Mon, 07/31/23 - 10:03 am
Big Pharma
Pharma CEOs
drug pricing
M&A
JNJ
Merck
GSK
GSK Expects Slower Uptake of RSV Vaccine Amid Record Sales for Shingles Shot
BioSpace
Wed, 07/26/23 - 11:40 am
GSK
earnings
vaccines
RSV
Arexvy
J&J, GSK's ViiV tout switching study showing patients prefer their long-acting HIV med Cabenuva over Gilead rival
Fierce Pharma
Tue, 07/25/23 - 09:20 pm
JNJ
GSK
ViiV
Gilead Sciences
HIV
Cabenuva
Biktarvy
Pfizer, Gilead, GSK to Capture Growing Infectious Diseases Market as J&J Pulls Back
BioSpace
Mon, 07/24/23 - 10:26 am
infectious diseases
Pfizer
Gilead Sciences
GSK
JNJ
GSK Returns Shigella Vaccine Candidate to LimmaTech as Drug-Resistant Cases Rise
BioSpace
Thu, 07/20/23 - 09:37 pm
GSK
vaccines
Shigella
LimmaTech
GSK-funded report on adult vaccination rates finds major global declines in recent years
Fierce Pharma
Wed, 07/19/23 - 05:51 pm
GSK
vaccines
vaccination rates
GSK underscores organ damage risks for lupus patients in It Will campaign
Medical Marketing and Media
Fri, 07/14/23 - 10:19 am
GSK
DTC ads
lupus
Haleon plots massive layoffs in UK and beyond to save cost: report
Fierce Pharma
Thu, 07/13/23 - 08:50 pm
GSK
Haleon
consumer healthcare
layoffs
UK
Biopharma’s green shoots thriving in summer sun as deal activity returns
Fierce Biotech
Tue, 07/11/23 - 11:18 pm
M&A
Eli Lilly
Siglion Therapeutics
DiCE Therapeutics
GSK
Bellus Health
GSK's ViiV explores novel pathway to bring long-acting HIV med Cabenuva to tough-to-treat patients
Fierce Pharma
Thu, 07/6/23 - 10:07 pm
GSK
ViiV Healthcare
HIV
Cabenuva
Biopharma buyouts bounce back
EP Vantage
Wed, 07/5/23 - 10:17 am
M&A
Amgen
Astellas
Eli Lilly
GSK
Horizon Therapeutics
Merck
Novartis
Pfizer
Seagen
Gates Foundation, Wellcome Pledge $550M for Phase III Trial of GSK’s TB Vaccine
BioSpace
Wed, 06/28/23 - 10:33 pm
Gates Foundation
GSK
vaccines
tuberculosis
GSK’s daprodustat obtains positive opinion from EMA CHMP
Pharmaceutical Business Review
Tue, 06/27/23 - 10:12 am
EMA
Europe
GSK
CHMP
daprodustat
chronic kidney disease
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »